Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

0001411690

Bionano develops and offers optical genome mapping (OGM) solutions. Their Stratys™ and Saphyr™ systems, along with VIA™ software, enable the discovery of structural variants in the genome. Bionano positions itself as an innovator in genomics, focusing on improving health through advanced technology.

87
Altamente Confiable
Puntuación de Confianza

Registro Oficial

Nombre Legal
Bionano Genomics, Inc.
Número de organización
0001411690
Número de IVA
261756290
Estado de la Empresa
Active
Dirección
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121
Códigos de Industria
Laboratory Analytical Instruments, 3826

Última verificación: 1/2/2026

Análisis de Calidad IA

Industria
Biotechnology
SSL/HTTPS
Seguro
Correo profesional
Correo de contacto
support@bionano.com

Desglose de Puntuación de Confianza

Registro Verificado35/35
Puntuación de Calidad52/60
Sentimiento de Noticias0/5

Enlaces Rápidos

Última actualización: 1/2/2026

🌟 Empresas similares de confianza

vTv Therapeutics Inc.

vTv Therapeutics Inc. logo
89/100 · Altamente Confiable

vTv Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of diabetes patients. They focus on developing oral, small molecule drug candidates. Their lead candidate is cadisegliatin, a potential adjunctive therapy to insulin for type 1 diabetes. They are also exploring indications for type 2 diabetes and other chronic conditions.

3980 PREMIER DR, Estados Unidos
Ver perfil

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. logo
86/100 · Altamente Confiable

Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel immunotherapies using foreign patterns to trigger the innate immune system, which teaches the immune system to recognize and kill cancer. Bolt was founded in 2015.

900 CHESAPEAKE DRIVE, Estados Unidos
Ver perfil

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. logo
86/100 · Altamente Confiable

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors.

825 INDUSTRIAL ROAD, Estados Unidos
Ver perfil